Oral bisphosphonates and atrial fibrillation.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18334526.
- Also identified by DOI 10.1136/bmj.39513.481065.80 and PMC identifier 2292276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The risk is negligible, and does not offset the benefits of reducing fractures
Medical subject headings
- Atrial Fibrillation
- Bone Density Conservation Agents
- Diphosphonates
- Fractures, Bone
- Osteoporosis